|
Market Closed -
OTC Markets
14:57:29 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 41.90 USD | +2.46% |
|
-0.17% | +15.23% |
| 09-25 | US FDA approves Mirum's drug for rare bone disorder | RE |
| 09-22 | European Pharma Leaders Push for National Reforms to Boost Investment | DJ |
| Market Cap | 11.53B 12.98B 10.78B 9.82B 18.49B 1,250B 18.75B 130B 50.49B 636B 48.73B 47.67B 2,044B | P/E 2026 * |
11.7x | P/E 2027 * | 11.9x |
|---|---|---|---|---|---|
| Enterprise Value | 10.19B 11.48B 9.53B 8.69B 16.36B 1,105B 16.58B 115B 44.65B 563B 43.09B 42.16B 1,808B | EV / Sales 2026 * |
2.22x | EV / Sales 2027 * | 1.97x |
| Free-Float |
40.65% | Yield 2026 * |
1.09% | Yield 2027 * | 1.09% |
| Markets | Quality | ||
|---|---|---|---|
OTC Markets
| IPSEY | Delayed | |
Deutsche Boerse AG
| I7G0 | Delayed | |
|
Börse Stuttgart
| I7G0 | Delayed |
Last Transcript: Ipsen S.A.
| 1 day | +2.46% | ||
| 1 week | -0.17% | ||
| 1 month | -14.76% | ||
| 3 months | -9.90% | ||
| 6 months | -9.51% | ||
| Current year | +15.23% |
| 1 week | 40.31 |  | 41.98 |
| 1 month | 40.31 | | 46.5 |
| Current year | 34.34 | | 51.1 |
| 1 year | 32.68 | | 51.1 |
| 3 years | 25.11 | | 51.1 |
| 5 years | 21.17 | | 51.1 |
| 10 years | 9.1 | | 51.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Loew
CEO | Chief Executive Officer | 59 | 2020-06-30 |
| Chief Executive Officer | 57 | 2019-12-31 | |
Pierrick Lefranc
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Antoine Flochel
BRD | Director/Board Member | 61 | 2005-08-29 |
| Chairman | 68 | 2010-11-21 | |
Carol Xueref
BRD | Director/Board Member | 69 | 2012-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.46% | -0.17% | - | - | 13.23B | |
| -0.62% | -0.10% | +50.70% | +114.07% | 1,031B | |
| -2.30% | -3.90% | +39.50% | +66.07% | 638B | |
| -0.63% | -1.94% | +12.26% | +74.38% | 462B | |
| -1.03% | -2.88% | +71.35% | +39.69% | 359B | |
| -0.03% | -3.91% | +34.28% | +39.35% | 335B | |
| -1.58% | +0.39% | +17.92% | +25.77% | 273B | |
| -2.02% | -3.20% | +7.60% | +8.38% | 253B | |
| -3.38% | +0.29% | +44.32% | +51.54% | 228B | |
| -1.04% | -2.56% | +32.88% | +96.82% | 185B | |
| Average | -1.02% | -0.36% | +34.53% | +57.34% | 418.21B | |
| Weighted average by Cap. | -1.24% | -0.35% | +38.05% | +69.18% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.58B 5.16B 4.29B 3.91B 7.36B 497B 7.46B 51.87B 20.08B 253B 19.38B 18.96B 813B | 4.68B 5.27B 4.38B 3.99B 7.52B 508B 7.62B 53B 20.52B 259B 19.8B 19.37B 831B |
| Net income | 1.01B 1.14B 943M 859M 1.62B 109B 1.64B 11.41B 4.42B 55.67B 4.26B 4.17B 179B | 989M 1.11B 925M 843M 1.59B 107B 1.61B 11.19B 4.33B 54.6B 4.18B 4.09B 175B |
| Net Debt | -1.33B -1.5B -1.25B -1.14B -2.14B -145B -2.17B -15.08B -5.84B -73.6B -5.64B -5.51B -236B | -2.3B -2.59B -2.15B -1.96B -3.68B -249B -3.74B -25.98B -10.06B -127B -9.71B -9.5B -407B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-30 | US$41.90 | +2.46% | 171 |
| 26-09-28 | US$40.89 | -2.60% | 515 |
| 26-09-25 | US$41.98 | +0.02% | 1,642 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IPN Stock
- IPSEY Stock
Select your edition
All financial news and data tailored to specific country editions
